Shangke Biomedicine (Shanghai) Co., Ltd. was established at the end of 2007, and has now become a closed-loop industrial chain enterprise integrating biocatalysis and synthetic biology technology research and development, pharmaceutical intermediates and apis production, and pharmaceutical preparation production。With four major technology platforms, we have developed more than 50 enzyme libraries and coenzyme products (including NMN, NAD, NADP, NADH, NADPH, FMN, FAD, PAPS, etc.).。The main business of the Group includes: the development and application of biological enzymes, the development, production and sales of pharmaceutical intermediates, apis and functional chemicals, and pharmaceutical preparations;CRO/CDMO services for biological enzymes, pharmaceutical intermediates, apis and pharmaceutical preparations。